Figure 6.

Neurological deficit scores (A) and infarct volume percentages (B) following transient MCAO over seven days. The neurobehavioral outcome in the HPX-administration (1.86 mg/ml) group was far superior as compared with the vehicle group. In addition, the brain infarct volumes were significantly reduced. ## P<0.01 in comparison with the vehicle group. (n=8 for each group).

Dong et al. BMC Neuroscience 2013 14:58   doi:10.1186/1471-2202-14-58
Download authors' original image